Xylem Inc. has announced better-than-expected first-quarter earnings, exceeding Zacks Consensus Estimates by 11.9% with adjusted earnings of 47 cents per share and revenue of $1,272 million. The company saw a 12% year-over-year increase in orders, totaling $1,715 million, while managing a significant reduction in long-term debt by 23%. However, it faced a notable decline in adjusted EBITDA, which fell 15.8% from last year, and maintains a poor Growth Score of F.
“Xylem · reported · earnings · better-than-expected results for first-quarter 2022”
“Xylem · surpassed · Zacks Consensus Estimate · by 11.9%”
“Xylem · reported · adjusted earnings · 47 cents per share”
“Xylem · reported · revenue · $1,272 million”
“Xylem · surpassed · Zacks Consensus Estimate for revenue · of $1,227 million”
“Xylem · reported · orders · $1,715 million”
“Xylem · increased · orders year over year · 12%”
“Xylem · experienced · a decrease in adjusted EBITDA · 15.8% from the year-ago quarter’s level”
“Xylem · reported · cash and cash equivalents · $1,117 million”
“Xylem · used · net cash from operating activities · $81 million”
“Xylem · paid out · dividends · $55 million”
“Xylem · expects · organic revenue growth · 4-6% for 2022”